New research consortium
23.04.2024
New research consortium to combat vector-borne diseases
The genus flavivirus includes several human pathogens, such as Zika, dengue, West Nile virus (WNV) and yellow fever virus, which persist as major threats to global public health. Yellow4FLAVI, coordinated by Giovanna Barba-Spaeth, Institut Pasteur, comprises 13 partner institutions and is supported by the European Union with with € 8 million. The aim is to use the 17D yellow fever vaccine as a model to understand the molecular basis of long-lasting immune protection.
Two members of the TRR237, Anne Krug and Simon Rothenfußer, are both leaders of subprojects in the consortium. Congratulations!